DUCTAL CARCINOMA IN SITU

This study tests a shorter, 5-day radiation treatment for early-stage breast cancer or DCIS after surgery. The goal is to see if this approach causes fewer side effects and is as effective as longer treatments at preventing cancer from coming back. About 90 women aged 50 and olde…

This study tests whether active monitoring with hormone therapy can safely manage ductal carcinoma in situ (DCIS), a very early form of breast cancer, instead of immediate surgery. About 400 women with hormone-sensitive DCIS will receive either standard or experimental hormone th…

This early-stage study tests whether a vaccine targeting a protein called MUC1 can help prevent breast cancer in women with ductal carcinoma in situ (DCIS), a very early form of the disease. About 50 women will receive either standard hormone therapy alone or hormone therapy plus…

This study tests a new tattoo ink called Magic Ink that fades over time, used to mark the exact spot for daily radiation in women with breast cancer. About 30 women will get the Magic Ink instead of standard permanent ink. Researchers will check if it's safe and if it stays visib…

This study is for people with non-invasive breast cancer (DCIS) who are having a mastectomy. Normally, surgeons remove lymph nodes at the same time, but most of these removals are unnecessary. The study uses a special iron-based dye called Magtrace that stays in the lymph nodes f…

This study tests a new method for marking the area where breast cancer was removed during surgery. The goal is to help radiation doctors see the exact spot on scans, making radiotherapy more precise and reducing the need for repeat surgeries. About 50 adults with early-stage brea…

This study looks at how social and economic factors (like stress or support) relate to inflammation in women newly diagnosed with breast cancer. About 200 participants will fill out questionnaires and give one blood sample. The goal is to better understand these connections, not …